Announcement on Adjustment of the Grant Price under the 2021 Restricted Share Incentive Plan
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(688289)"Sansure Biotech Inc."Announcement on Adjustment of the Grant Price under the 2021 Restricted Share Incentive Plan
Filed with SSE · Stock code 688289 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Sansure Biotech Inc. on 6ix
Story so far
- (688289)"Sansure Biotech Inc."Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificates for Relevant Products
- (688289)"Sansure Biotech Inc."Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Approval of Registration for Medium-term Notes
Earlier from Sansure Biotech
- (688289)"Sansure Biotech Inc."Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificates for Relevant Products
- (688289)"Sansure Biotech Inc."Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Approval of Registration for Medium-term Notes
- Announcement on Results of Completion of Execution of Certain Shares Held by the Former Shareholder Holding More Than 5% of the Shares
- Announcement on Resignation of the Board Secretary and Designation of the Chairman to Act as the Board Secretary
Follow Sansure Biotech into a list and get an email when it puts out news.
Follow Sansure Biotech